MNK1 expression increases during cellular senescence and modulates the subcellular localization of hnRNP A1

Experimental Cell Research

Volumn 318, Issue 5, 2012, Pages 500-508

  Ziaei, Samira ^a,b   Shimada, Naoko ^a   Kucharavy, Herman ^a   Hubbard, Karen ^a,b  

^a CITY COLLEGE OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

CGP57380; Fibroblasts; HnRNP A1; MNK1; p38 MAPK; Senescence

Indexed keywords

4 AMINO 5 (4 FLUOROANILINO)PYRAZOLO(3,4 D)PYRIMIDINE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MNK1 PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; CELL AGING; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; IC 50; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; IN VIVO STUDY; INHIBITION KINETICS; MODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; SENESCENCE;

EID: 84857059571     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.12.015     Document Type: Article

References (40)

1. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 1961, 25:585-621.
2. Cristofalo V.J., Pignolo R.J. Replicative senescence of human fibroblast-like cells in culture. Physiol. Rev. 1993, 73:617-638.
3. Takai H., Smogorzewska A., de Lange T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 2003, 13:1549-1556.
4. Maruyama J., Naguro I., Takeda K., Ichijo H. Stress-activated MAP kinase cascades in cellular senescence. Curr. Med. Chem. 2009, 16:1229-1235.
5. Severino J., Allen R.G., Balin S., Balin A., Cristofalo V.J. Is beta-galactosidase staining a marker of senescence in vitro and in vivo?. Exp. Cell Res. 2000, 257:162-171.
6. Coulthard L.R., White D.E., Jones D.L., McDermott M.F., Burchill S.A. p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol. Med. 2009, 15:369-379.
7. Enslen H., Brancho D.M., Davis R.J. Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. EMBO J. 2000, 19:1301-1311.
8. Rittling S.R., Brooks K.M., Cristofalo V.J., Baserga R. Expression of cellcycle-dependent genes in young and senescent WI-38 fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:3316-3320.
9. Wang W., Chen J.X., Liao R., Deng Q., Zhou J.J., Huang S., Sun P. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol. Cell. Biol. 2002, 22:3389-3403.
10. Iwasa H., Han J., Ishikawa F. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 2003, 8:131-144.
11. Dreyfuss G., Kim V.N., Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol. 2002, 3:195-205.
12. Krecic A.M., Swanson M.S. hnRNP complexes: composition, structure, and function. Curr. Opin. Cell Biol. 1999, 11:363-371.
13. Piñol-Roma S., Choi Y.D., Matunis M.J., Dreyfuss G. Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins. Genes Dev. 1988, 2:215-227.
14. Cáceres J.F., Stamm S., Helfman D.M., Krainer A.R. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 1994, 265:1706-1709.
15. Mayeda A., Krainer A.R. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 1992, 68:365-375.
16. Yang X., Bani M.R., Lu S.J., Rowan S., Ben-David Y., Chabot B. The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5' splice site selection in vivo. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:6924-6928.
17. Piñol-Roma S., Dreyfuss G. Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature 1992, 355:730-732.
18. Iervolino A., Santilli G., Trotta R., Guerzoni C., Cesi V., Bergamaschi A., Gambacorti-Passerini C., Calabretta B., Perrotti D. hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis. Mol. Cell. Biol. 2002, 22:2255-2266.
19. Bonnal S., Pileur F., Orsini C., Parker F., Pujol F., Prats A.C., Vagner S. Heterogeneous nuclear ribonucleoprotein A1 is a novel internal ribosome entry site trans-acting factor that modulates alternative initiation of translation of the fibroblast growth factor 2 mRNA. J. Biol. Chem. 2005, 280:4144-4153.
20. Izaurralde E., Jarmolowski A., Beisel C., Mattaj I.W., Dreyfuss G., Fischer U. A role for the M9 transport signal of hnRNP A1 in mRNA nuclear export. J. Cell Biol. 2011, 137:27-35.
21. Svitkin Y.V., Ovchinnikov L.P., Dreyfuss G., Sonenberg N. General RNA binding proteins render translation cap dependent. EMBO J. 1996, 15:7147-7155.
22. Hubbard K., Dhanaraj S.N., Sethi K.A., Rhodes J., Wilusz J., Small M.B., Ozer H.L. Alteration of DNA and RNA binding activity of human telomere binding proteins occurs during cellular senescence. Exp. Cell Res. 1995, 218:241-247.
23. Zhu D., Xu G., Ghandhi S., Hubbard K. Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: implications for cellular senescence. J. Cell. Physiol. 2002, 193:19-25.
24. Shimada N., Rios I., Moran H., Sayers B., Hubbard K. p38 MAP kinase-dependent regulation of the expression level and subcellular distribution of heterogeneous nuclear ribonucleoprotein A1 and its involvement in cellular senescence in normal human fibroblasts. RNA Biol. 2009, 6:293-304.
25. Hubbard K., Ozer H.L. Senescence & immortalization of human cells. Cell Growth, Differentiation & Senescence 1999, 281-300. Oxford University Press, New York. G.P. Studsinski (Ed.).
26. Harlow E., Lane D.P. Antibodies: a Laboratory Manual 1988, 359. Cold Spring Harbor Laboratory Press, New York. E. Harlow, D.P. Lane (Eds.).
27. Buxadé M., Parra J.L., Rousseau S., Shpiro N., Marquez R., Morrice N., Bain J., Espel E., Proud C.G. The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 2005, 23:177-189.
28. Pyronnet S. Phosphorylation of the cap-binding protein eIF4E by the MAPK-activated protein kinase Mnk1. Biochem. Pharmacol. 2000, 60:1237-1243.
29. Rousseau S., Morrice N., Peggie M., Campbell D.G., Gaestel M., Cohen P. Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs. EMBO J. 2002, 21:6505-6514.
30. Knauf U., Tschopp C., Gram H. Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2. Mol. Cell. Biol. 2001, 21:5500-5511.
31. Guil S., Long J.C., Cáceres J.F. hnRNP A1 relocalization to the stress granules reflects a role in the stress response. Mol. Cell. Biol. 2006, 26:5744-5758.
32. Allemand E., Guil S., Myers M., Moscat J., Cáceres J.F., Krainer A.R. Regulation of heterogenous nuclear ribonucleoprotein A1 transport by phosphorylation in cells stressed by osmotic shock. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:3605-3610.
33. Bianchini A., Loiarro M., Bielli P., Busà R., Paronetto M.P., Loreni F., Geremia R., Sette C. Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells. Carcinogenesis 2008, 29:2279-2288.
34. Ruggero D., Montanaro L., Ma L., Xu W., Londei P., Cordon-Cardo C., Pandolfi P.P. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat. Med. 2004, 10:484-486.
35. Syntichaki P., Troulinaki K., Tavernarakis N. eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans. Nature 2007, 445:922-926.
36. Tavernarakis N. Protein synthesis and aging: eIF4E and the soma vs. germline distinction. Cell Cycle 2007, 6:1168-1171.
37. Zuberek J., Wyslouch-Cieszynska A., Niedzwiecka A., Dadlez M., Stepinski J., Augustyniak W., Gingras A.C., Zhang Z., Burley S.K., Sonenberg N., Stolarski R., Darzynkiewicz E. Phosphorylation of eIF4E attenuates its interaction with mRNA 5' cap analogs by electrostatic repulsion: intein-mediated protein ligation strategy to obtain phosphorylated protein. RNA 2003, 9:52-61.
38. Ueda T., Watanabe-Fukunaga R., Fukuyama H., Nagata S., Fukunaga R. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol. Cell. Biol. 2004, 24:6539-6549.
39. Michael W.M., Siomi H., Choi M., Piñol-Roma S., Nakielny S., Liu Q., Dreyfuss G. Signal sequences that target nuclear import and nuclear export of pre-mRNA-binding proteins. Cold Spring Harb. Symp. Quant. Biol. 1995, 60:663-668.
40. Bishop N.A., Lu T., Yankner B.A. Neural mechanisms of ageing and cognitive decline. Nature 2010, 464:529-535.